Skip to main content
. 2022 Mar 3;23(1):104–111. doi: 10.1080/15384047.2021.2011643

Figure 4.

Figure 4.

The role of ARID family subunits in the modulation of the tumor immune microenvironment. a:ARID mutated patients have increased CD4 + T lymphocytes in gastric cancer and colorectal cancer. b:ARID mutated patients have increased CD8 + T lymphocytes in various types of malignancies. c:Mutated ARID1A, mutated ARID1B and mutated ARID2 were associated with the enhancement of PD-L1 expression in gastric cancer and colorectal cancer.